Kepos Capital LP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Kepos Capital LP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$762,000
-5.1%
68,3680.0%0.08%
+28.3%
Q1 2019$803,000
-12.0%
68,3680.0%0.06%
-14.3%
Q4 2018$913,000
-4.8%
68,3680.0%0.07%
+42.9%
Q3 2018$959,000
-23.7%
68,368
-14.5%
0.05%
-23.4%
Q2 2018$1,257,000
-4.4%
79,9370.0%0.06%
-16.9%
Q1 2018$1,315,00079,9370.08%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders